UPDATE: Cowen Downgrades Theravance Biopharma (TBPH) to Market Perform
Tweet Send to a Friend
(Updated - August 24, 2021 5:56 AM EDT)
Cowen analyst Marc Frahm downgraded Theravance Biopharma (NASDAQ: TBPH) from Outperform ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Cowen analyst Marc Frahm downgraded Theravance Biopharma (NASDAQ: TBPH) from Outperform ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
